Yaky Yanay
2017
In 2017, Yaky Yanay earned a total compensation of $3.3M as Co, CEO and President at Pluristem Therapeutics, a 662% increase compared to previous year.
Compensation breakdown
| Salary | $253,037 |
|---|---|
| Stock Awards | $3,050,000 |
| Other | $22,093 |
| Total | $3,325,130 |
Yanay received $3.1M in stock awards, accounting for 92% of the total pay in 2017.
Yanay also received $253K in salary and $22.1K in other compensation.
Rankings
In 2017, Yaky Yanay's compensation ranked 3,201st out of 14,666 executives tracked by ExecPay. In other words, Yanay earned more than 78.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,201 out of 14,666 | 78th |
Division Manufacturing | 1,101 out of 5,772 | 81st |
Major group Chemicals And Allied Products | 304 out of 2,075 | 85th |
Industry group Drugs | 234 out of 1,731 | 87th |
Industry Biological Products, Except Diagnostic Substances | 45 out of 313 | 86th |
Source: SEC filing on April 3, 2018.
Yanay's colleagues
We found two more compensation records of executives who worked with Yaky Yanay at Pluristem Therapeutics in 2017.
News
Pluristem Therapeutics CEO Yaky Yanay's 2023 pay jumps 111% to $2.7M
May 1, 2024
Pluristem Therapeutics CEO Yaky Yanay's 2022 pay falls 86% to $1.3M
February 27, 2023
Pluristem Therapeutics Chairman Zami Aberman's 2020 pay falls 54% to $501K
April 8, 2021
Pluristem Therapeutics Chairman Zami Aberman's 2019 pay jumps 85% to $1.1M
May 20, 2020
Pluristem Therapeutics CEO Zami Aberman's 2018 pay falls 83% to $593K
April 25, 2019